ARTICLE | Company News
GeneScan, LGC Ltd deal
November 11, 2002 8:00 AM UTC
GEP received a non-exclusive worldwide license from LGC to use CYP2D6*4 gene variant in GEP’s Pharm-O-Kin biochip pharmacogenetic typing assay. GEP said the CYP2D6*4 gene codes for an enzyme in the li...